Total Funding
66
76
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
93037
RxE2 is a company that decentralized clinical trials a cost-effective reality.
David Stark: Senior Director Of Business DevelopmentPast Role: AmStem, CEO- Gerald Finken: CEOPast Role: Clinical Supplies Management, Founder & CEO
About the Company
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists, as trusted medication experts, to use their extensive patient insights and make clinical trials more accessible to patients, everywhere. This, in
turn, vastly reduces clinical trial timelines and costs, helps patients achieve better health outcomes, and provides study sponsors with more accurate data.
